MoneyWorks4Me

Aurobindo Pharma informs about disclosure

31 Mar 2025 Evaluate
Aurobindo Pharma has informed that it has disclosed the receipt of the above referred cautionary e-mails to the stock exchanges on March 28, 2025. The company has submitted the disclosure again in the prescribed format as Annexure to this letter.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..